<!doctype html>
<html>
    <head>
        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>Langerhans Cell Histiocytosis: A Review with Focus on Musculoskeletal Manifestations</title>
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/reveal.css">
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/theme/black.css" id="theme">
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/highlight/monokai.css">
        <!-- Your custom styles remain unchanged -->
        <style>
        .reveal .slides {
            text-align: left;
        }
        .reveal h1, .reveal h2, .reveal h3 {
            text-transform: none;
            text-align: center;
            margin-bottom: 10px; /* Reduce space below headings */
        }
        .reveal h2 {
            font-size: 1.5em; /* Slightly smaller h2 to save space */
            margin-top: 5px;
        }
        .reveal img {
            max-height: 450px; /* Slightly reduced from 500px */
            margin: 0 auto;
            display: block;
        }
        .image-row {
            display: flex;
            justify-content: space-around;
            align-items: center;
            margin-bottom: 5px; /* Reduce space below image rows */
        }
        .image-row img {
            max-height: 380px; /* Slightly reduced from 400px */
            margin: 5px; /* Reduced from 10px */
        }
        /* New styles for slides with images */
        section:has(img) ul {
            font-size: 0.75em; /* Slightly smaller text */
            margin-top: 5px; /* Reduced from 10px */
            padding-left: 20px; /* Reduce left padding of lists */
        }
        section:has(.image-row) ul {
            font-size: 0.75em;
            margin-top: 5px;
            padding-left: 20px;
        }
        section:has(img) li {
            margin-bottom: 0.2em; /* Reduced from 0.3em */
            line-height: 1.2; /* Tighter line height */
        }
        section:has(.image-row) li {
            margin-bottom: 0.2em;
            line-height: 1.2;
        }
        /* Fallback for browsers that don't support :has */
        .smaller-text ul {
            font-size: 0.75em;
            margin-top: 5px;
            padding-left: 20px;
        }
        .smaller-text li {
            margin-bottom: 0.2em;
            line-height: 1.2;
        }
        .attribution {
            font-size: 0.65em; /* Slightly smaller */
            font-style: italic;
            text-align: center;
            margin-top: 2px; /* Reduced from 5px */
            margin-bottom: 2px;
            color: #aaa;
        }
        /* Compact layout for slides with images and attribution */
        .compact-slide h2 {
            margin-bottom: 5px;
        }
        .compact-slide .image-row {
            margin-bottom: 2px;
        }
        .compact-slide .attribution {
            margin-top: 1px;
            margin-bottom: 1px;
        }
        /* Adjust vertical spacing in reveal.js */
        .reveal .slides section {
            padding: 0;
        }
        
        /* Modal styles */
        /* Removed Modal Styles */
        
        /* Adjust vertical spacing in reveal.js */
        .reveal .slides section {
            padding: 0;
        }
        
        /* Caption styles */
        .small-caption {
            font-size: 0.75em;
            margin-bottom: 5px;
        }

        .tooltip {
            position: relative;
            display: inline-block;
            border-bottom: 1px dotted #000;
            cursor: help;
        }

        .tooltip .tooltip-text {
            visibility: hidden;
            width: 300px;
            background-color: #555;
            color: #fff;
            text-align: left;
            border-radius: 6px;
            padding: 8px;
            position: absolute;
            z-index: 1;
            bottom: 125%;
            left: 50%;
            margin-left: -150px;
            opacity: 0;
            transition: opacity 0.3s;
            font-size: 0.8em;
        }

        .tooltip .tooltip-text::after {
            content: "";
            position: absolute;
            top: 100%;
            left: 50%;
            margin-left: -5px;
            border-width: 5px;
            border-style: solid;
            border-color: #555 transparent transparent transparent;
        }

        .tooltip:hover .tooltip-text {
            visibility: visible;
            opacity: 1;
        }
        
    </style>
</head>
<body>
    <div class="reveal">
        <div class="slides">
            <!-- Slide 1: Title -->
            <section>
                <h1>Interesting Case Conference</h1>
                <h3>Langerhans Cell Histiocytosis</h3>
                <p style="text-align: center;">Daniel Hofstedt, DO</p>
                <p style="text-align: center;">Tuesday, March 11, 2025</p>
            </section>

            <!-- Slide 2: Case Presentation -->
            <section>
                <h2>Case Presentation</h2>
                <ul>
                    <li class="fragment">11-year-old female (initially 9 years old) with persistent left thigh pain for several months in 2023</li>
                    <li class="fragment">Initially diagnosed as "growing pains" but developed limping by November 2023</li>
                    <li class="fragment">Medical history: IgA deficiency, eczema, ADHD, anxiety</li>
                </ul>
            </section>

            <!-- Slide 3: Initial Imaging -->
            <section class="smaller-text compact-slide">
                <h2>Initial Imaging</h2>
                <div class="image-row">
                    <img src="images/image1.png" alt="Anteroposterior (AP) radiograph showing a well-circumscribed lucent lesion in the left femoral diaphysis" data-description="AP radiograph of left femur">
                    <img src="images/image2.png" alt="Lateral radiograph illustrating a narrow zone of transition with surrounding periosteal reaction in the left femur" data-description="Lateral radiograph of left femur">
                </div>
                <ul>
                    <li class="fragment">Well-circumscribed lucent lesion in the femoral diaphysis</li>
                    <li class="fragment">Narrow zone of transition with surrounding periosteal reaction</li>
                </ul>
            </section>

            <!-- Slide 4: Advanced Imaging - MRI -->
            <section class="smaller-text compact-slide">
                <h2>Advanced Imaging - MRI</h2>
                <div class="image-row">
                    <img src="images/image5.png" alt="Coronal T1-weighted MRI showing a heterogeneous lesion in the mid to distal left femoral diaphysis" data-description="Coronal T1 MRI">
                    <img src="images/image6.png" alt="Coronal STIR MRI highlighting extensive reactive changes in the surrounding medullary canal" data-description="Coronal STIR MRI">
                    <img src="images/image8.png" alt="Post-contrast MRI demonstrating periosteal new bone formation with mild expansion" data-description="Post-contrast MRI">
                </div>
                <ul>
                    <li class="fragment">Heterogeneous lesion involving mid to distal left femoral diaphysis</li>
                    <li class="fragment">Extensive reactive changes in surrounding medullary canal</li>
                    <li class="fragment">Periosteal new bone formation with mild expansion</li>
                </ul>
            </section>

            <!-- Slide 5: Biopsy Findings -->
            <section class="smaller-text compact-slide">
                <h2>Biopsy Findings</h2>
                <div style="text-align: center;">
                    <img src="images/image10.png" alt="CT-guided biopsy image showing the procedure performed in December 2023 for Langerhans cell histiocytosis" data-description="CT-guided biopsy">
                </div>
                <ul>
                    <li class="fragment">CT-guided biopsy performed December 2023</li>
                    <li class="fragment">Pathology: Positive for Langerhans cell histiocytosis</li>
                    <li class="fragment">IHC: Positive for CD1a, langerin, and S100; BRAF negative</li>
                </ul>
            </section>

            <!-- Slide 6: Follow-up PET/CT -->
            <section class="smaller-text compact-slide">
                <h2>Follow-up PET/CT</h2>
                <div class="image-row">
                    <figcaption class="small-caption">Initial PET/CT (February 2024)</figcaption>
                    <img src="images/image11.png" alt="Initial PET/CT scan from February 2024 showing SUVmax of 3.3 in the left femoral lesion" data-description="Initial PET/CT">
                    <figcaption class="small-caption">Follow-up PET/CT (May 2024)</figcaption>
                    <img src="images/image12.png" alt="Follow-up PET/CT scan from May 2024 showing decreased uptake (SUVmax 1.7) in the left femoral lesion" data-description="Follow-up PET/CT">
                </div>
                <ul>
                    <li class="fragment">Initial PET (2/2024): SUVmax 3.3 in left femoral lesion</li>
                    <li class="fragment">Follow-up PET (5/2024): Decreased uptake (SUVmax 1.7) and extent</li>
                    <li class="fragment">Most recent PET (12/2024): No evidence of residual/recurrent disease</li>
                </ul>
            </section>

            <!-- Slide 7: What is Langerhans Cell Histiocytosis? -->
            <section class="smaller-text compact-slide">
                <h2>What is Langerhans Cell Histiocytosis?</h2>
                <div style="display: flex; justify-content: space-between; align-items: center;">
                    <div style="width: 60%;">
                        <ul>
                            <li class="fragment" data-fragment-index="1">Neoplastic proliferation of myeloid dendritic cells with Langerhans cell features</li>
                            <li class="fragment" data-fragment-index="2">Characterized by CD1a, S100, and CD207 (langerin) expression</li>
                            <li class="fragment" data-fragment-index="3">Birbeck granules on electron microscopy (pathognomonic organelles)</li>
                            <li class="fragment" data-fragment-index="4">Not derived from normal skin Langerhans cells despite similar appearance</li>
                        </ul>
                    </div>
                    <div style="width: 35%;" class="fragment" data-fragment-index="3">
                        <img src="images/birbeck-granules.jpg" alt="Birbeck granules" style="max-height: 250px;">
                        <p class="attribution">Electron microscopy showing Birbeck granules</p>
                    </div>
                </div>
            </section>

            <!-- Slide 8: Classification of LCH -->
            <section>
                <h2>Classification of LCH</h2>
                <ul>
                    <li class="fragment">Unifocal (localized): Single bone/few bones (~70% of cases)</li>
                    <li class="fragment">Multifocal unisystem: Multiple bones and/or other single system (~20%)</li>
                    <li class="fragment">Multifocal multisystem: Disseminated involvement of multiple systems (~10%)</li>
                </ul>
            </section>

            <!-- Slide 9: Epidemiology and Clinical Presentation -->
            <section>
                <h2>Epidemiology and Clinical Presentation</h2>
                <ul>
                    <li class="fragment">Most common in children 1-3 years; can occur at any age</li>
                    <li class="fragment">Male predominance (M:F = 2:1)</li>
                    <li class="fragment">Presentation varies by site of involvement:
                        <ul>
                            <li class="fragment">Bone pain and swelling (most common)</li>
                            <li class="fragment">Skin rash</li>
                            <li class="fragment">Diabetes insipidus (pituitary involvement)</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 10: Musculoskeletal Manifestations - Skeletal Distribution -->
            <section>
                <h2>Musculoskeletal Manifestations</h2>
                <h3>Skeletal Distribution</h3>
                <ul>
                    <li class="fragment">Occurs in ~80% of LCH patients</li>
                    <li class="fragment">Common sites:
                        <ul>
                            <li class="fragment">Skull (most common)</li>
                            <li class="fragment">Long bones (femur, humerus, tibia)</li>
                            <li class="fragment">Pelvis</li>
                            <li class="fragment">Spine</li>
                            <li class="fragment">Ribs</li>
                            <li class="fragment">Mandible</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 11: Skull Lesions -->
            <section class="smaller-text compact-slide">
                <h2>Skull Lesions</h2>
                <div class="image-row">
                    <img src="images/zaveri-skull-punched-out-lesion.png" alt="Punched-out skull lesion" data-description="Punched-out skull lesion">
                    <img src="images/zaveri-geographic-skull.png" alt="Geographic skull appearance" data-description="Geographic skull appearance">
                </div>
                <p class="attribution">Zaveri J, et al. Radiographics 2014</p>
                <ul>
                    <li class="fragment">"Punched-out" lytic lesions with beveled edges</li>
                    <li class="fragment">Geographic skull appearance when lesions coalesce</li>
                    <li class="fragment">Key teaching point: Lack of periosteal reaction in calvarial lesions</li>
                </ul>
            </section>

            <!-- Slide 12: Long Bone Lesions -->
            <section class="smaller-text compact-slide">
                <h2>Long Bone Lesions</h2>
                <div class="image-row">
                    <img src="images/image1.png" alt="Anteroposterior (AP) radiograph showing a well-circumscribed lucent lesion in the left femoral diaphysis" data-description="Our case">
                    <img src="images/companion-case-1.png" alt="Companion case" data-description="Companion case">
                </div>
                <ul>
                    <li class="fragment">Diaphyseal or metaphyseal predilection</li>
                    <li class="fragment">Early: Lytic, expansile, aggressive appearance</li>
                    <li class="fragment">Later: Sclerotic margin develops (chronic lesions)</li>
                    <li class="fragment">Unlike skull lesions, periosteal reaction is common</li>
                </ul>
            </section>

            <!-- Slide 13: Spine Involvement -->
            <section class="smaller-text compact-slide">
                <h2>Spine Involvement</h2>
                <div style="text-align: center;">
                    <img src="images/zaveri-coronal-ct-spine.png" alt="Spine involvement" data-description="Spine involvement">
                </div>
                <p class="attribution">Zaveri J, et al. Radiographics 2014</p>
                <ul>
                    <li class="fragment">Classic finding: Vertebra plana</li>
                    <li class="fragment">Symmetric, uniform collapse of vertebral body</li>
                    <li class="fragment">Preserved intervertebral disk spaces</li>
                </ul>
            </section>

            <!-- Slide 14: Differential Diagnosis -->
            <section>
                <h2>Differential Diagnosis</h2>
                <h3 style="font-size: 0.6em;">Diaphyseal and Metaphyseal Lytic Lesions in Children</h3>
                <table style="font-size: 0.5em; width: 100%; border-collapse: collapse; margin-top: 10px;">
                    <thead>
                        <tr>
                            <th style="width: 25%; text-align: left; border-bottom: 1px solid #555; padding: 5px;">Diagnosis</th>
                            <th style="width: 55%; text-align: left; border-bottom: 1px solid #555; padding: 5px;">Key Differentiators and Buzzwords</th>
                            <th style="width: 20%; text-align: center; border-bottom: 1px solid #555; padding: 5px;">Example</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr class="fragment">
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Langerhans Cell Histiocytosis</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Well-defined lytic lesion, narrow zone of transition, mild periosteal reaction, possible soft tissue component</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333; text-align: center;"><img src="images/companion-case-1.png" style="max-height: 80px; max-width: 100%;" alt="LCH example"></td>
                        </tr>
                        <tr class="fragment">
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Osteomyelitis/Brodie's abscess</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333;">"Penumbra sign" on MRI, sequestrum, cloaca, involucrum</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333; text-align: center;"><img src="images/osteomyelitis.jpg" style="max-height: 80px; max-width: 100%;" alt="Osteomyelitis example"><p class="attribution tooltip" style="padding: 0; margin: 0;">Zairi M<span class="tooltip-text">Zairi M, Boussetta R, Msakni A, Mohseni AA, Nessib MN. Subacute osteomyelitis of the tibial diaphysis associated with Brodie's abscess: A rare case report of a four-year-old child. Int J Surg Case Rep. 2021 Dec;89:106453. doi: 10.1016/j.ijscr.2021.106453. Epub 2021 Sep 28. PMID: 34775323; PMCID: PMC8593451.</span></p></td>
                        </tr>
                        <tr class="fragment">
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Ewing sarcoma</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333;">More aggressive appearing, permeative destruction, larger soft tissue mass, "onion-skin" periostitis</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333; text-align: center;"><img src="images/ewing.png" style="max-height: 80px; max-width: 100%;" alt="Ewing sarcoma example"></td>
                        </tr>
                        <tr class="fragment">
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Non-ossifying fibroma</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Eccentric, cortically-based, thin sclerotic margins, scalloped borders, no periosteal reaction</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333; text-align: center;"><img src="images/nof.png" style="max-height: 80px; max-width: 100%;" alt="NOF example"></td>
                        </tr>
                        <tr class="fragment">
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Bone cysts (SBC/ABC)</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333;">Expansile with thin cortex, "fallen fragment sign" (SBC with pathologic fracture), "fluid-fluid levels" (ABC)</td>
                            <td style="padding: 5px; border-bottom: 1px solid #333; text-align: center;"><img src="images/bone-cyst.png" style="max-height: 80px; max-width: 100%;" alt="Bone cyst example"></td>
                        </tr>
                    </tbody>
                </table>
            </section>

            <!-- Slide 15: Extraskeletal Manifestations - Brief Overview -->
            <section>
                <h2>Extraskeletal Manifestations</h2>
                <h3>Brief Overview</h3>
                <ul>
                    <li class="fragment">CNS: Pituitary stalk thickening → diabetes insipidus</li>
                    <li class="fragment">Pulmonary: Nodules → cysts (predominantly upper lobes)</li>
                    <li class="fragment">Skin: Seborrheic-like rash, xanthomatous lesions</li>
                    <li class="fragment">Liver/spleen: Organomegaly, sclerosing cholangitis</li>
                    <li class="fragment">Lymph nodes: Cervical lymphadenopathy, Mesenteric lymphadenopathy</li>
                </ul>
            </section>

            <!-- Slide 16: Pathologic Features -->
            <section>
                <h2>Pathologic Features</h2>
                <ul>
                    <li class="fragment">Proliferation of Langerhans cells with grooved/folded nuclei</li>
                    <li class="fragment">Admixed eosinophils, lymphocytes, neutrophils</li>
                    <li class="fragment">Diagnostic markers:
                        <ul>
                            <li>CD1a+</li>
                            <li>Langerin (CD207)+</li>
                            <li>S100+</li>
                            <li>BRAF V600E mutation in ~50% of cases</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 17: Treatment and Prognosis -->
            <section>
                <h2>Treatment and Prognosis</h2>
                <ul>
                    <li class="fragment">Unifocal disease: Often observation alone or local therapy</li>
                    <li class="fragment">Multifocal/multisystem: Systemic chemotherapy ± steroids</li>
                    <li class="fragment">Our patient: Good response with resolution of metabolic activity</li>
                    <li class="fragment">Prognosis:
                        <ul>
                            <li>Excellent for unifocal osseous disease (>90% survival)</li>
                            <li>Guarded for multisystem disease with risk organ involvement</li>
                        </ul>
                    </li>
                </ul>
            </section>

            <!-- Slide 18: Key Teaching Points -->
            <section>
                <h2>Key Teaching Points</h2>
                <ul>
                    <li class="fragment">"Punched-out" skull lesions with beveled edges are pathognomonic</li>
                    <li class="fragment">Vertebra plana = think LCH in children</li>
                    <li class="fragment">Periosteal reaction present in long bone lesions, absent in skull</li>
                    <li class="fragment">Classic triad: Lytic bone lesions + exophthalmos + diabetes insipidus</li>
                </ul>
            </section>

            <!-- Slide 19: Diagnostic Approach for Suspected Histiocytic Disorders -->
            <section class="smaller-text compact-slide">
                <h1 style="font-size: 36px;">Diagnostic Approach for Suspected Histiocytic Disorders</h1>
                <div style="text-align: center;">
                    <img src="images/goyal-paper-lch-dx-flowcart.jpg" alt="Diagnostic flowchart" data-description="Diagnostic flowchart">
                </div>
                <p class="attribution">
                    <span class="tooltip">Goyal G, et al. Mayo Clin Proc 2019
                      <span class="tooltip-text">Goyal G, Young JR, Koster MJ, et al. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019;94(10):2054-2071.</span>
                    </span>
                  </p>
                <ul>
                    <li>Initial evaluation: Whole-body PET-CT, labs, biopsy</li>
                    <li>Role of BRAF V600E testing</li>
                </ul>
            </section>

            <!-- Slide 20: Summary -->
            <section>
                <h2>Summary</h2>
                <ul>
                    <li class="fragment">Langerhans Cell Histiocytosis has variable clinical manifestations</li>
                    <li class="fragment">Classic imaging appearance depends on anatomic location</li>
                    <li class="fragment">Unifocal disease has excellent prognosis</li>
                    <li class="fragment">Our patient shows complete metabolic response on follow-up</li>
                </ul>
            </section>

            <!-- Slide 21: References -->
            <section>
                <h2>References</h2>
                <ul>
                    <li style="font-size: 26px;">Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019 Oct;94(10):2054-2071. doi: 10.1016/j.mayocp.2019.02.023. Epub 2019 Aug 28. PMID: 31472931.</li>
                    <li style="font-size: 26px;">Zaveri J, La Q, Yarmish G, Neuman J. More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders. Radiographics. 2014 Nov-Dec;34(7):2008-24. doi: 10.1148/rg.347130132. PMID: 25384298.</li>
                    <li style="font-size: 26px;">Zairi M, Boussetta R, Msakni A, Mohseni AA, Nessib MN. Subacute osteomyelitis of the tibial diaphysis associated with Brodie's abscess: A rare case report of a four-year-old child. Int J Surg Case Rep. 2021 Dec;89:106453. doi: 10.1016/j.ijscr.2021.106453. Epub 2021 Sep 28. PMID: 34775323; PMCID: PMC8593451.</li>
                </ul>
            </section>

            <!-- Slide 22: Thank You -->
            <section>
                <h2>Thank You</h2>
                <p style="text-align: center;">Questions?</p>
            </section>
        </div>
    </div>

    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/dist/reveal.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/markdown/markdown.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/highlight/highlight.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/notes/notes.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.6.0/plugin/zoom/zoom.js"></script>
    <script>
        Reveal.initialize({
            hash: true,
            plugins: [ RevealMarkdown, RevealHighlight, RevealNotes, RevealZoom ]
        });
    </script>
</body>
</html>
